Hepatobiliary Cancers, Version 2.2021

被引:653
作者
Benson III, Al B. [1 ]
D'Angelica, Michael I. [2 ]
Abbott, Daniel E. [3 ]
Anaya, Daniel A. [4 ]
Anders, Robert [5 ]
Are, Chandrakanth [6 ]
Bachini, Melinda [7 ]
Borad, Mitesh [8 ]
Brown, Daniel [9 ]
Burgoyne, Adam [10 ]
Chahal, Prabhleen [11 ,12 ]
Chang, Daniel T. [13 ]
Cloyd, Jordan [14 ,15 ]
Covey, Anne M. [2 ]
Glazer, Evan S. [16 ]
Goyal, Lipika [17 ]
Hawkins, William G. [18 ,19 ]
Iyer, Renuka [20 ]
Jacob, Rojymon [21 ]
Kelley, R. Kate [22 ]
Kim, Robin [23 ]
Levine, Matthew [24 ]
Palta, Manisha [25 ]
Park, James O. [26 ]
Raman, Steven [27 ]
Reddy, Sanjay [28 ]
Sahai, Vaibhav [29 ]
Schefter, Tracey [30 ]
Singh, Gagandeep [31 ]
Stein, Stacey [32 ]
Vauthey, Jean-Nicolas [33 ]
Venook, Alan P. [22 ]
Yopp, Adam [34 ]
McMillian, Nicole R. [35 ]
Hochstetler, Cindy [35 ]
Darlow, Susan D. [35 ]
机构
[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[5] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[6] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA
[7] Cholangiocarcinoma Fdn, Kearns, UT USA
[8] Mayo Clin, Ctr Canc, Rochester, MN USA
[9] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[10] UC San Diego Moores Canc Ctr, San Diego, CA USA
[11] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA
[12] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[13] Stanford Canc Inst, Stanford, CA USA
[14] Ohio State Univ, Comprehens Canc Ctr, James Canc Hosp, Columbus, OH 43210 USA
[15] Solove Res Inst, Columbus, OH USA
[16] Univ Tennessee, Hlth Sci Ctr, St Jude Childrens Res Hosp, Knoxville, TN USA
[17] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
[18] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO 63110 USA
[19] Washington Univ, Sch Med, St Louis, MO USA
[20] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA
[21] ONeal Comprehens Canc Ctr UAB, Birmingham, AL USA
[22] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[23] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[24] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[25] Duke Canc Inst, Durham, NC USA
[26] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, 1124 Columbia St, Seattle, WA 98104 USA
[27] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA
[28] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[29] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA
[30] Univ Colorado, Ctr Canc, Boulder, CO 80309 USA
[31] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[32] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA
[33] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[34] UT Southwestern Simmons Comprehens Canc Ctr, Dallas, TX USA
[35] Natl Comprehens Canc Network, Plymouth Meeting, PA USA
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2021年 / 19卷 / 05期
关键词
UNRESECTABLE HEPATOCELLULAR-CARCINOMA; RANDOMIZED CONTROLLED-TRIAL; BODY RADIATION-THERAPY; PHASE-II TRIAL; DOXORUBICIN-ELUTING BEADS; PORTAL-VEIN EMBOLIZATION; CONVENTIONAL TRANSARTERIAL CHEMOEMBOLIZATION; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; PERCUTANEOUS RADIOFREQUENCY ABLATION; CLASSIFYING MICROVASCULAR INVASION;
D O I
10.6004/jnccn.2021.0022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The NCCN Guidelines for Hepatobiliary Cancers focus on the screening, diagnosis, staging, treatment, and management of hepa-tocellular carcinoma (HCC), gallbladder cancer, and cancer of the bile ducts (intrahepatic and extrahepatic cholangiocarcinoma). Due to the multiple modalities that can be used to treat the disease and the complications that can arise from comorbid liver dysfunction, a multidisciplinary evaluation is essential for determining an optimal treatment strategy. A multidisciplinary team should include hepatol-ogists, diagnostic radiologists, interventional radiologists, surgeons, medical oncologists, and pathologists with hepatobiliary cancer ex-pertise. In addition to surgery, transplant, and intra-arterial thera-pies, there have been great advances in the systemic treatment of HCC. Until recently, sorafenib was the only systemic therapy option for patients with advanced HCC. In 2020, the combination of atezo-lizumab and bevacizumab became the first regimen to show superi -or survival to sorafenib, gaining it FDA approval as a new frontline standard regimen for unresectable or metastatic HCC. This article discusses the NCCN Guidelines recommendations for HCC.
引用
收藏
页码:541 / 565
页数:25
相关论文
共 259 条
[1]   Treatment of large and advanced hepatocellular carcinoma [J].
Abdalla, Eddie K. ;
Denys, Alban ;
Hasegawa, Kiyoshi ;
Leung, Thomas W. T. ;
Makuuchi, Masatoshi ;
Murthy, Ravi ;
Ribero, Dario ;
Zorzi, Daria ;
Vauthey, Jean-Nicolas ;
Torzilli, Guido .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (04) :979-985
[2]   Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma [J].
Abdel-Rahman, Omar M. ;
Elsayed, Zeinab .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02)
[3]   Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma [J].
Abou-Alfa, G. K. ;
Meyer, T. ;
Cheng, A. -L. ;
El-Khoueiry, A. B. ;
Rimassa, L. ;
Ryoo, B. -Y. ;
Cicin, I. ;
Merle, P. ;
Chen, Y. H. ;
Park, J. -W. ;
Blanc, J. -F. ;
Bolondi, L. ;
Klumpen, H. -J. ;
Chan, S. L. ;
Zagonel, V. ;
Pressiani, T. ;
Ryu, M. -H. ;
Venook, A. P. ;
Hessel, C. ;
Borgman-Hagey, A. E. ;
Schwab, G. ;
Kelley, R. K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) :54-63
[4]   Multidisciplinary Management of Hepatocellular Carcinoma Improves Access to Therapy and Patient Survival [J].
Agarwal, Parul D. ;
Phillips, Paulina ;
Hillman, Luke ;
Lucey, Michael R. ;
Lee, Fred ;
Mezrich, Josh D. ;
Said, Adnan .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2017, 51 (09) :845-849
[5]   The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015 [J].
Akinyemiju, Tomi ;
Abera, Semaw ;
Ahmed, Muktar ;
Alam, Noore ;
Alemayohu, Mulubirhan Assefa ;
Allen, Christine ;
Al-Raddadi, Rajaa ;
Alvis-Guzman, Nelson ;
Amoako, Yaw ;
Artaman, Al ;
Ayele, Tadesse Awoke ;
Barac, Aleksandra ;
Bensenor, Isabela ;
Berhane, Adugnaw ;
Bhutta, Zulfiqar ;
Castillo-Rivas, Jacqueline ;
Chitheer, Abdulaal ;
Choi, Jee-Young ;
Cowie, Benjamin ;
Dandona, Lalit ;
Dandona, Rakhi ;
Dey, Subhojit ;
Dicker, Daniel ;
Phuc, Huyen ;
Ekwueme, Donatus U. ;
Zaki, Maysaa El Sayed ;
Fischer, Florian ;
Furst, Thomas ;
Hancock, Jamie ;
Hay, Simon I. ;
Hotez, Peter ;
Jee, Sun Ha ;
Kasaeian, Amir ;
Khader, Yousef ;
Khang, Young-Ho ;
Kumar, G. Anil ;
Kutz, Michael ;
Larson, Heidi ;
Lopez, Alan ;
Lunevicius, Raimundas ;
Malekzadeh, Reza ;
McAlinden, Colm ;
Meier, Toni ;
Mendoza, Walter ;
Mokdad, Ali ;
Moradi-Lakeh, Maziar ;
Nagel, Gabriele ;
Nguyen, Quyen ;
Nguyen, Grant ;
Ogbo, Felix .
JAMA ONCOLOGY, 2017, 3 (12) :1683-1691
[6]   STEREOTACTIC BODY RADIOTHERAPY FOR PRIMARY HEPATOCELLULAR CARCINOMA [J].
Andolino, David L. ;
Johnson, Cynthia S. ;
Maluccio, Mary ;
Kwo, Paul ;
Tector, A. Joseph ;
Zook, Jennifer ;
Johnstone, Peter A. S. ;
Cardenes, Higinia R. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04) :E447-E453
[7]  
[Anonymous], LIV IMAG REP DAT VER
[8]  
[Anonymous], OPTN Policies Effective as of December 5 2024
[9]  
[Anonymous], **NON-TRADITIONAL**
[10]   The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis [J].
Arrieta, Oscar ;
Cacho, Bernardo ;
Morales-Espinosa, Daniela ;
Ruelas-Villavicencio, Ana ;
Flores-Estrada, Diana ;
Hernandez-Pedro, Norma .
BMC CANCER, 2007, 7 (1)